Aktiesnakken — Oktober 2010
-
svær ligning....
-
spørgsmålet om man tror at genmab vil falde mere på en skuffelse end stige på en overraskelse. Det tror jeg...
-
man lad os nu sige for sjov skyld inden vi allesammen skal i Irma at salget løfter sig +74% så kan der ligger en del i det
-
det er fordi folk spekulere i en overraskelse og derefter sælger...
-
men omvendt vil man nok ærgre sig hvis den neuroitis...
-
hej vandmand
-
en akties sentiment ligger vel på en linie mellem frygt og grådighed. Frygten har haft tag i genmab i 2 år
-
jo 67 blev brudt med manér
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind